Compare BETA & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BETA | BLLN |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.6B |
| IPO Year | 2025 | 2025 |
| Metric | BETA | BLLN |
|---|---|---|
| Price | $24.86 | $93.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $35.25 | ★ $126.71 |
| AVG Volume (30 Days) | ★ 1.6M | 786.8K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 103.40 |
| EPS | N/A | ★ 0.48 |
| Revenue | $35,616,000.00 | ★ $305,112,000.00 |
| Revenue This Year | $14.75 | $46.29 |
| Revenue Next Year | $918.13 | $30.14 |
| P/E Ratio | ★ N/A | $195.85 |
| Revenue Growth | ★ 135.99 | 99.97 |
| 52 Week Low | $13.43 | $61.96 |
| 52 Week High | $36.43 | $150.44 |
| Indicator | BETA | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 65.62 | 34.97 |
| Support Level | $14.52 | $73.46 |
| Resistance Level | $31.55 | $99.29 |
| Average True Range (ATR) | 1.75 | 7.36 |
| MACD | 0.49 | -5.07 |
| Stochastic Oscillator | 81.01 | 6.91 |
BETA Technologies Inc is an aerospace company. The group has developed an electric aircraft platform and propulsion systems that are positioned to transform the aviation industry forward into a new phase of growth. It designs, manufactures, and sells high-performance electric aircraft, modern electric propulsion systems, charging systems, and components. The group also invested in the underlying infrastructure of this breakthrough technology, which is critical to bringing electric aviation to life. The group has developed a differentiated presence in North America and is well-positioned to expand globally. Its products and services are Aircraft, Charge, Motor, Battery, Flight Controls, and Training. It has one operating segment: Development and Manufacturing of Electric Aircraft.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.